Literature DB >> 25496151

Biobanking sustainability--experiences of the Australian Breast Cancer Tissue Bank (ABCTB).

Jane E Carpenter1, Christine L Clarke.   

Abstract

Sustainability of biorepositories is a key issue globally. This article is a description of the different strategies and mechanisms used by the Australian Breast Cancer Tissue Bank (ABCTB) in developing and operating the resource since its inception in 2005. ABCTB operates according to a hub and spoke model, with a central management hub that is responsible for overall management of the resource including financial, ethical, and legal processes, researcher applications for material, clinical follow-up, information/database activities, and security. A centralized processing laboratory also operates from the hub site where DNA and RNA extractions are performed, digital imaging of stained tumor sections occurs, and specimens are assembled for dispatch for research projects. ABCTB collection sites where donors are identified, consent obtained, and specimens collected and processed for initial storage are located across Australia. Each of the activities of the resource requires financial support and different sources of revenue, some of which are allocated to a specific function of the ABCTB. Different models are in use at different collection centers where local variations may exist and local financial support may sometimes be obtained. There is also significant in-kind support by clinics and diagnostic and research facilities that house the various activities of the resource. However, long-term financial commitment to ensure the survival of the resource is not in place, and forward planning of operations remains challenging under these circumstances.

Entities:  

Mesh:

Year:  2014        PMID: 25496151     DOI: 10.1089/bio.2014.0055

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  4 in total

1.  Achieving and Maintaining Sustainability in Biobanking Through Business Planning, Marketing, and Access.

Authors:  Marianne K Henderson; Kirstin Goldring; Daniel Simeon-Dubach
Journal:  Biopreserv Biobank       Date:  2016-11-18       Impact factor: 2.300

2.  Critical Financial Challenges for Biobanking: Report of a National Cancer Institute Study.

Authors:  Abhi Rao; Jim Vaught; Bill Tulskie; Dorie Olson; Hana Odeh; Jeffrey McLean; Helen M Moore
Journal:  Biopreserv Biobank       Date:  2019-01-14       Impact factor: 2.300

3.  Biospecimen User Fees: Global Feedback on a Calculator Tool.

Authors:  Lise A M Matzke; Sindy Babinszky; Alex Slotty; Anna Meredith; Tania Castillo-Pelayo; Marianne K Henderson; Daniel Simeon-Dubach; Brent Schacter; Peter H Watson
Journal:  Biopreserv Biobank       Date:  2016-08-30       Impact factor: 2.300

4.  Modeling Clinical Processes to Consent Research Donors of Remnant Biospecimens in an Outpatient Cardiology Clinic.

Authors:  Stephanie E Soares; Nicholas R Anderson; Leslie J Solis; Javier E López
Journal:  Biopreserv Biobank       Date:  2019-12-26       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.